Alnylam Pharmaceuticals
ALNY
#578
Rank
NZ$61.09 B
Marketcap
$472.03
Share price
-0.94%
Change (1 day)
83.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of December 2024 : NZ$7.45 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are NZ$7.45 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2024-12-31NZ$7.51 B24.14%
2023-12-31NZ$6.05 B8.42%
2022-12-31NZ$5.58 B4.72%
2021-12-31NZ$5.33 B12.96%
2020-12-31NZ$4.72 B32.77%
2019-12-31NZ$3.55 B51.48%
2018-12-31NZ$2.34 B-16.41%
2017-12-31NZ$2.80 B54.06%
2016-12-31NZ$1.82 B-10.01%
2015-12-31NZ$2.02 B47.02%
2014-12-31NZ$1.37 B169.25%
2013-12-31NZ$0.51 B46.42%
2012-12-31NZ$0.34 B-3.24%
2011-12-31NZ$0.36 B-29.14%
2010-12-31NZ$0.50 B-23.09%
2009-12-31NZ$0.66 B-30.66%
2008-12-31NZ$0.95 B48.27%
2007-12-31NZ$0.64 B89.23%
2006-12-31NZ$0.34 B136.76%
2005-12-31NZ$0.14 B55.31%
2004-12-31NZ$92.64 M71.17%
2003-12-31NZ$54.12 M75.81%
2002-12-31NZ$30.78 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$1.78 B-76.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$66.39 B 790.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.96 B-6.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.86 B-48.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.14 B-98.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$179.77 B 2,311.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$242.98 B 3,159.26%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$69.14 B 827.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel